News Sentiment

BMY sentiment intelligence

Bristol-Myers Squibb Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 56 Balanced news tone 39 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 54.00 Week of 19 Jun 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-5.5% over one week, -9.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

3 Reasons to Buy Bristol Myers Squibb Stock

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -5.5% Price reacting lower
Trend fit Trend inactive -9.2% over four weeks
Fair value 9.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 22
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
simplywall.st 6
MarketWatch 2
marketscreener.com 2
StockStory 2
The Motley Fool 1
Bristol Myers Squibb 1
Kavout 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 9
Capital return 7
Deals and strategy 1
Analyst action 1
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-39 of 39